Literature DB >> 15219004

Characterisation of pleural inflammation occurring after primary spontaneous pneumothorax.

A De Smedt1, E Vanderlinden, C Demanet, M De Waele, A Goossens, M Noppen.   

Abstract

The aim of this study was to examine the inflammatory reaction occurring in the pleural space of patients suffering from primary spontaneous pneumothorax (PSP) using pleural lavage, which was performed in patients with PSP and in healthy control subjects (essential hyperhidrosis patients undergoing thoracoscopy for sympathicolysis treatment). Cellular and solute composition of lavage fluid, peripheral blood and parietal pleural biopsies were analysed. PSP lavage fluid showed an increase in all differentiated leucocytes, but most strikingly eosinophils and neutrophils. In the blood of patients with PSP, the total number of leucocytes and the absolute number of eosinophils, neutrophils and monocytes were also significantly increased. The time in which air was present in the pleural space was positively correlated with the increase of eosinophils in lavage fluid, parietal pleura and blood. Eosinophilic cationic protein was elevated after PSP and strongly correlated with the absolute number of lavage eosinophils. Chemo and cytokine analysis in lavage fluid showed differences in concentrations of interleukin (IL)-5, IL-6, IL-8, IL-12p40, tumour necrosis factor-alpha and RANTES, but not of eotaxin. Surprisingly, high levels of lipopolysaccharide binding protein were also measured. Primary spontaneous pnumothorax is associated with a substantial pleural inflammatory reaction. The authors hypothesise that mechanical stretch factors, lipopolysaccharide binding protein/lipopolysaccharide complexes or other environmental components trigger pleural inflammation after primary spontaneous pnumothorax.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15219004     DOI: 10.1183/09031936.04.00079304

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  7 in total

1.  Correlation of matrix metalloproteinase-2 and -9 expression with recurrences in primary spontaneous pneumothorax patients.

Authors:  Wen-Chin Chiu; Yi-Chen Lee; Yu-Han Su; Chee-Yin Chai; Stephen Chu-Sung Hu; Shyng-Shiou F Yuan; Shah-Hwa Chou
Journal:  J Thorac Dis       Date:  2016-12       Impact factor: 2.895

2.  Induction of heme oxygenase-1, biliverdin reductase and H-ferritin in lung macrophage in smokers with primary spontaneous pneumothorax: role of HIF-1alpha.

Authors:  Delphine Goven; Anne Boutten; Véronique Leçon-Malas; Joëlle Marchal-Sommé; Paul Soler; Jorge Boczkowski; Marcel Bonay
Journal:  PLoS One       Date:  2010-05-28       Impact factor: 3.240

3.  Folliculin haploinsufficiency causes cellular dysfunction of pleural mesothelial cells.

Authors:  Shouichi Okamoto; Hiroki Ebana; Masatoshi Kurihara; Keiko Mitani; Etsuko Kobayashi; Takuo Hayashi; Yasuhito Sekimoto; Koichi Nishino; Mizuto Otsuji; Toshio Kumasaka; Kazuhisa Takahashi; Kuniaki Seyama
Journal:  Sci Rep       Date:  2021-05-24       Impact factor: 4.379

4.  Eosinophilic ascites due to severe eosinophilic ileitis.

Authors:  Namrata Setia; Peter Ghobrial; Pantanowitz Liron
Journal:  Cytojournal       Date:  2010-09-17       Impact factor: 2.091

5.  Drainless thoracoscopic surgery should be avoided in primary spontaneous pneumothorax with pleural adhesion.

Authors:  Chieh-Kuo Lin; Ka-I Leong; Cheng-Hung How; Hu-Lin Christina Wang; Chao-Yu Liu
Journal:  Interact Cardiovasc Thorac Surg       Date:  2022-09-09

6.  A combination of predispositions and exposures as responsible for acute eosinophilic pneumonia.

Authors:  Simona Amiconi; Bertrand Hirl
Journal:  Multidiscip Respir Med       Date:  2014-01-30

7.  Multiple-site bleeding at pleural adhesions and massive hemothorax following percutaneous coronary intervention with stent implantation: A case report.

Authors:  Xiaoli Luo; Weibin Shi; Xiaoqun Zhang; Xiaoli Yang; Wei Wang; Chunyu Zeng; Hongyong Wang
Journal:  Exp Ther Med       Date:  2018-01-02       Impact factor: 2.447

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.